(Q54340369)

28 May 2018

title

Molecular mechanism underlying the detection of colorectal cancer by 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography. (English)

1 reference

28 May 2018

0 references

1 reference

Kunihiko Izuishi

1

1 reference

28 May 2018

Yuka Yamamoto

2

1 reference

28 May 2018

Takanori Sano

3

1 reference

28 May 2018

Ryusuke Takebayashi

4

1 reference

28 May 2018

Yoshihiro Nishiyama

5

1 reference

28 May 2018

Hirohito Mori

6

1 reference

28 May 2018

Tsutomu Masaki

7

1 reference

28 May 2018

Asahiro Morishita

8

1 reference

28 May 2018

Yasuyuki Suzuki

9

1 reference

28 May 2018

publication date

8 November 2011

1 reference

28 May 2018

Journal of Gastrointestinal Surgery

published in

1 reference

28 May 2018

volume

16

1 reference

28 May 2018

issue

2

1 reference

28 May 2018

page(s)

394-400

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/s11605-011-1727-z

exact match

0 references

cites work

Noninvasive assessment of regulable transferred-p53 gene expression and evaluation of therapeutic response with FDG-PET in tumor model.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

HIF-1alpha: a valid therapeutic target for tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Diagnosis of maxillofacial tumor with L-3-[18f]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Glucose metabolism in cancer. Evidence that demethylation events play a role in activating type II hexokinase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Hexokinase and glucose-6-phosphatase activity in woodchuck model of hepatitis virus-induced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Impact of 18-fluorodeoxyglucose positron emission tomography on the management of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Regulation of the Warburg effect in early-passage breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Cancer's molecular sweet tooth and the Warburg effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Oncogenic alterations of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Why do cancers have high aerobic glycolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Hypoxia, glucose metabolism and the Warburg's effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Oxygen sensing by HIF hydroxylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1727-Z

Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.

21 January 2018

1 reference

12 December 2020

In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET

1 reference

12 December 2020

18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression

1 reference

12 December 2020

GLUT1 expression in tissue and (18)F-FDG uptake.

1 reference

12 December 2020

Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.

1 reference

12 December 2020

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil

1 reference

12 December 2020

Noninvasive grading of musculoskeletal tumors using PET

1 reference

12 December 2020

Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy.

1 reference

12 December 2020

PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine

1 reference

12 December 2020

Growth regulation of the PCNA gene

1 reference

12 December 2020

Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.

1 reference

12 December 2020

Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors

1 reference

12 December 2020

10.1007/S11605-011-1727-Z

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018